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ConclusionsSigns & Symptoms
Implications for Nursing Care
Image courtesy of Mayo Clinic
Melanoma usually presents in areas most often exposed to the sun, but may present 
anywhere on the body. “Thinking of "ABCDE" can help you remember what to look for. 
Assess moles or other pigmentations on the skin for:
~Asymmetry: The shape of one half does not match the other half.
~ Border that is irregular: The edges are often ragged, notched, or blurred in outline. The 
pigment may spread into the surrounding skin.
~ Color that is uneven: Shades of black, brown, and tan may be present. Areas of white, 
gray, red, pink, or blue may also be seen.
~ Diameter: There is a change in size, usually an increase. Melanomas can be tiny, but most 
are larger than the size of a pea (larger than 6 millimeters or about 1/4 inch).
~ Evolving: The mole has changed over the past few weeks or months”
(“National Cancer Institute,” 2011, para 1)
Hidden melanomas may be found in 
unexpected areas of the body such as 
under the nail beds of the fingers and 
toes, palms of hands and feet, mucous 
membranes and body openings,  or 
within the eye (“Mayo Clinic,” 2016).
“Although changes in a mole or 
pigmentation on an area of one’s skin 
my be an early symptom of melanoma, 
late symptoms (or symptoms that the 
melanoma has metastasized)  include:
~ Lymph nodes – may feel hard and 
swollen
~ Skin – hard lumps may appear
~ Lungs – one  may be breathless or have 
a cough that doesn’t get better
~ Liver – one may feel pain in the upper 
right side of the abdomen
~ Bones – one may have an ache in 
his/her bones
~ Brain – a headache that doesn’t go 
away.”
(“We Are MacMillan. Cancer Support,” 
2018, para. 1)
Melanoma accounts for approximately 
5% of skin cancers and is the most fatal 
type. It is the fastest growing of all 
malignancies in men and the second 
fastest growing malignancy in women 
(Castellania et al., 2017). Due to the high 
mortality rate of Melanoma, there has 
been an increase in interest and scientific 
studies in recent years. (Basi HR, 
Alicezaei, Ahovan, & Moradi, 2017).
“Advanced melanoma is highly invasive 
and metastasizes quickly to the lymph 
nodes, lungs, liver, and brain (“We Are 
MacMillan. Cancer Support,”2018, 
para.1).”
One study performed, “Does Proximity of 
the Primary Tumour to the Lymph Node 
Basin, in Patients with Malignant 
Melanoma, Influence the Chance of 
Sentinel Node Positivity?,” showed a link 
between the proximity of a melanoma 
lesion to the lymph nodes and the 
increase chance of lymph node 
metastasis (Hunt et al, 2017). With this 
information in mind, it is especially 
important to assess moles and skin 
discolorations that are in hard-to-see (or 
often covered by clothes) places proximal 
to the trunk of the body.
Doctors usually do not deem a patient 
cured once a melanoma has been 
removed because of the risk that it may 
return in the years following. Instead, 
doctors use time increments of five years 
to assess survival rates. Studies have 
shown that the earlier the stage of 
melanoma when a patient receives the 
diagnosis, the longer the survival rate. 
(“Bupa,”2018)
The most frequently occurring 
malignancy in the United States is skin 
cancer (when taking into account all 
types of skin cancer). Skin cancer occurs 
more often than colon, breast, prostate, 
and lung cancers combined. 1/5 
Americans will have some form of skin 
cancer at some point in his or her 
lifetime. It is important for a health care 
professional to distinguish melanoma 
from other types of skin cancer due to it 
invasiveness.
Prevention from acquiring melanoma is 
the first line of defense. Ways a person 
can avoid melanoma include:
~ Avoiding direct sunlight, (stay in the 
shade) between 11am and 3pm when 
ultraviolet rays are strongest.
~ Wearing clothing such as hats, 
sunglasses, and long sleeves to cover 
sun-exposed skin.
~ Cover any sun-exposed skin with a high 
sun protection factor (SPF) sun screen of 
at least 30 or higher. (Pullen, Whitehead, 
& Pastwa, 2011)
Melanoma begins as a small change in an 
area of the skin and is very treatable if 
detected early.
Early detection and removal of 
melanoma  are the second line of 
defense. Scraping, freezing or surgical 
removal at the earliest opportunity is 
crucial to prevent the melanoma from 
growing thicker, wider, or metastasizing.
In biopsies of melanoma of the skin, 
studies have shown that an increase in 
mitotic activity correlates with an 
increase in depth of the malignant cells. 
An increase in mitotic activity could also 
mean an increase in tumor growth and 
metastasis. This information is useful to 
determine the appropriate treatment 
and depth of excision of the malignancy
(Basi HR, Alicezaei, Ahovan, & Moradi, 
2017). 
After removal of the melanoma, 
radiotherapy, immunotherapy, 
chemotherapy, and targeted therapies 
used to treat advanced melanomas and 
are specific to the type and distance of 
metastasis of the melanomas.  It is 
important for studies (such as 
angiogenesis inhibitors and proteomics) 
to continue to lower the mortality rate of 
melanoma (Deepanwitta & Tackett, 
2016).
Those with a history of any type of 
melanoma will always be at risk of re-
emerging melanomas and should 
continue with yearly head-to-toe skin 
examinations by a Dermatologist.
Malignant Melanoma is a type of skin 
cancer that stems from melanocytes. 
These are the pigment producing cells 
that gives the skin its color. Mutated 
melanocytes grow to be malignant 
melanoma (Castellania et al., 2017). 
Although the exact cause of melanoma is 
unclear, an increased exposure to 
ultraviolet radiation has been linked to 
obtaining this type of cancer. It is 
possible that a genetic link may also be 
involved in some cases of melanoma. 
Factors that increase a person’s risk of 
contracting melanoma include:
~ A family history of melanoma.
~ A history of one or more severe sun 
burns (especially blistering sun buns).
~ An excessive exposure to ultraviolet 
light (such as tanning beds or having a 
job that requires one to work out in the 
sun every day).
~ Having multiple moles or moles of 
irregular shapes or sizes (atypical  
moles).
~ Having fair or lighter pigmented skin, 
blue or green eyes, or those with blond 
or red hair.
~ Living at higher elevations or closer to 
the equator where there is more 
ultraviolet radiation and the light is more 
direct.
~ Having a suppressed immune system 
(including those with the HIV virus or 
AIDS,  who have received an organ 
transplant, or who are receiving 
immunotherapy, 
(“Mayo Clinic,” 2016, para 20)
Treatments
Early stages of melanoma are best treated 
by surgical removal of the malignant areas 
of skin.  If one is unable to undergo 
surgical removal of the melanoma, 
therapies such as radiotherapy, scraping 
or freezing off the melanoma, or 
treatment with a cream called imiquimod 
(“Bupa,” 2018, para.21) have shown 
effectiveness in removal of the melanoma.
Radiotherapy, Immunotherapy, 
Chemotherapy, and targeted therapies are 
used to treat advanced melanomas 
(“Bupa,”2018). Late stages of melanoma 
are more difficult to treat, resistant to 
apoptosis, and often deadly due to 
resistance to chemotherapy drugs or other 
treatments (Cox, 2015). 
Specific treatments for advanced 
melanoma are as follows:
~ Twenty different genes are linked to 
inhibiting malignant metastasis. Studies 
involving metastasis inhibitors are being 
performed, but not yet available for 
clinical use. Metastasis is inhibited  and 
apoptosis is encouraged in melanoma cells 
by a cysteine protease inhibitor called  
Cystatin C .
~ Apoptosis of melanoma cells  are also 
encouraged  by  prompting the MAPK and 
PI3K signaling pathway, which are two 
pathways that melanoma  cells proliferate.                                                                          
~ The chemotherapy agent Dacerbazine 
has show to provide some effectiveness to 
prevent melanoma DNA replication.                                                                              
~ Vemurafenib, also a chemotherapeutic 
agent and BRAF V600E antagonist, is 
effective in treating BRAF V600E mutant 
melanoma, but a resistance to this drug is 
often quickly acquired.          
~ A Biologic response modifier, IL-2, has 
also produced long term remission for 
some melanoma patients, but have side 
effects such as nausea, vomiting, and 
fatigue     
~ Immunotherapy has been shown 
successful in a small percentage of 
patients using check point inhibitors, such 
as Ipilimumab,
~ Therapeutic, cell-killing viruses (such as 
T-vec) are being tested and have proven to 
have dual benefits by eradicating 
melanoma cells and encouraging a 
patient’s immune response to the cancer 
cells.
~ Since melanoma is a type of angiogenic 
cancer, Angiogenesis inhibitors such as 
bevicezuma, are being tested in clinical 
trials and used as an adjunct to 
chemotherapy.
(Cox, 2015).
Summer is here and it is an important time 
of year to teach about prevention and 
detection of skin cancer. Many people 
expose his/her skin (or a child’s skin) to 
harmful ultraviolet light produced by the 
sun without knowing the risk that are 
involved. Malignant melanoma or 
cutaneous melanoma is the most deadly 
type of skin cancer and “the number of 
people that have acquired melanoma has 
nearly doubled since 1973. Although 
melanoma only accounts for approximately 
1% of skin cancer diagnoses, it accounts for 
70 - 75% of skin cancer related deaths 
(Deepanwitta & Tackett, 2016. para 2).”
Melanoma is also a highly invasive cancer. 
Early detection is key to positive prognosis 
(late stage melanoma is usually not curable 
because it is invasive and metastasizes). As 
an advanced practice nurse, it is important 
to recognize and assess for melanoma, 
even if this is not the patients primary 
complaint, since early detection could be 
life-saving.
“There are many types of melanoma but 
the four most common types of melanoma 
include:
~ Superficial spreading melanoma accounts 
for 70% of all diagnosed melanomas. It 
occurs most often in the younger 
populations. This type of melanoma begins 
to grow along the top of the skin (in situ) 
and with time, will metastasize. Various 
colors (white, black, red, blue, brown, or 
tan) and irregular borders are typical for 
this melanoma.
~ Lentigo maligna usually occurs in the 
elderly population on skin that has been 
chronically exposed to direct sun light. It  
appears tan, brown, or dark brown in color. 
It is also a superficial type of melanoma 
that slowly becomes invasive.
~ Acral lentiginous melanoma is usually a 
black or brown pigmentation that grows 
under the nails or on the palms/soles of 
hands /feet. It is the most frequent 
melanoma in Asians and African-Americans, 
but is less frequently occurring in the 
Caucasian populations.
~ Nodular melanoma is visualized as a dark-
colored lump on your skin. This type of 
melanoma is highly invasive and grows into 
the skin unlike the other types of 
melanomas that grow across the top of the 
skin. It may be black, blue, red, white, grey, 
brown, or tan. This type of melanoma 
makes up approximately 10%-15% of 
diagnosed melanomas.
(“Skin Cancer Foundation,” 2018)
(Pullen, Whitehead, & Pastwa, 2011)
Image courtesy of Bupa
A thorough, yearly skin assessment for all patients, but especially those with a history of 
melanoma or at high risk of obtaining melanoma, is imperative to catch melanoma in its 
earliest stages. Inquire about any ulcerated or open areas of skin, areas that itch or burn, 
or any irregular pigmentations of the skin. Obtaining the patients family history of 
melanoma and history of ultraviolet light exposure is vital as well.
Nursing care is dependent upon the staging of the melanoma. Staging of a melanoma is a 
way to categorize the severity of the disease. Staging  identifies the depth of penetration 
that is involved with the melanoma and if any metastasis involved. Stage 0 tumors are in 
situ, stage1 are localized to the epidermis and dermis, stage 2 are usually over 1mm thick 
and may have ulceration or risk of spreading to nearby lymph nodes, stage 3 is localized 
metastasis and lymph node involvement, stage 4 is metastasis to other areas of the body, 
stage 5 is brain metastasis (“Skin Cancer Foundation,” 2018).
In early stages of melanoma, nursing care involves wound care and healing of the area of 
skin that has been excised as well as measures to prevent the return of future melanomas. 
Nursing care for later stages of melanoma may include wound care as well as managing 
treatments specific for the type and depth of melanoma involved. 
(Pullen, Whitehead, & Pastwa, 2011)
